An anthropometry study in polycystic ovary syndrome patients
Keywords:Polycystic ovaries, Anthropometry, Waist hip ratio, Waist height ratio, Body mass index
Background: Polycystic ovary syndrome (PCOS) a symptom complex, which is also known as hyperandrogenism anovulation, was first proposed by Stein and Leventhal in 1935.
Methods: This observational cross-sectional study was conducted in the obstetrics and gynaecology department of SPS Hospital, Ludhiana, Punjab and included 60 women with PCOS and 30 non PCOS women of age group 18-40 who met the inclusion criteria.
Results: The Mean BMI of study population was 26.39±4.17 in group A (PCOS) and 26.37±3.79 in group B (non PCOS). The calculated mean waist hip ratio of subjects was 0.73±0.08 in both groups. The mean waist height ratio of study population was 0.48±0.05 in group A and 0.49±0.04 in group B.
Conclusions: Anthropometric parameters are recommended as a screening tool in women with PCOS so as to improve endocrinological and metabolic disturbances not only to treat PCOS but also to reduce long term health risks. An early treatment for obesity should be a priority to prevent cardiometabolic complications in future.
Lath R, Shendye R, Jibhkate A. Insulin resistance and lipid profile in polycystic ovary syndrome. Asian J Biomed Pharm Sci. 2015;5(47):30-5.
Gupta V, Sharma S, Raina SK, Bedi GK. Clinical, ultrasonographic, and biochemical correlates of polycystic ovarian syndrome: a case-control study from a tertiary care center in North India. J Sci Soc. 2018;45(1):8-12.
Sam S. Obesity and polycystic ovary syndrome. Obesmanag. 2007;3(2):69-73.
Cristian-Ioan I, Nicolae C, Dan M. Lipid parameters in patients with polycystic ovary syndrome. Appl Med Inform. 2012;31(4):27-32.
Palomba S, Santagni S, Falbo A, LaSala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Women Health. 2015;7:745-63.
Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol Oxf. 2001;54(4):447-53.
Valkenburg O, Steegers-Theunissen RPM, Smedts HPM, Dallinga-Thie GM, Fauser BCJM, Westerveld EH, et al. A More atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metabol. 2007;93(2):470-6.
Berneis K, Rizzo M, Lazzaroni V, Fruzzetti F, Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2007;92(1):186-9.
Macut D, Panidis D, Glišić B, Spanos N, Petakov M, Bjekić J, et al. Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharm 2008:86(4):199-204.
Rocha MP, Marcondes JAM, Barcellos CRG, Hayashida SAY, Curi DDG, da Fonseca ÂM, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27(10):814-9.
Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect. 2013;3(2):206-16.
Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GLJ, Venu S. Correlations between anthropometry and lipid profile in women with PCOS. J Hum Reprod Sci. 2017;10(3):167-72.